Volume 23, Number 5—May 2017
Research
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
Figure 1

Figure 1. Binding of DENV immune serum to Zika virus virions. Zika virus and 4 DENV serotypes were captured by using plate-bound mouse monoclonal antibody 4G2 and incubated with serum from donors who had had a primary DENV, secondary DENV, or primary Zika virus infection. In 2 separate experiments (A, B), serum binding was detected by using a horseradish peroxidase–conjugated human IgG. C, D) Differential global binding of each virus was accounted for by subtracting background from native human serum and normalizing to a high binding serum common to both plates (DT144). DENV, dengue virus; NHS, naive human serum; OD, optical density.
Page created: April 14, 2017
Page updated: April 14, 2017
Page reviewed: April 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.